Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Voyager Therapeutics (VYGR) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to -$11.1 million.

  • Voyager Therapeutics' Other Working Capital Changes fell 11269.44% to -$11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.7 million, marking a year-over-year increase of 5194.49%. This contributed to the annual value of -$44.8 million for FY2024, which is 57633.31% down from last year.
  • As of Q3 2025, Voyager Therapeutics' Other Working Capital Changes stood at -$11.1 million, which was down 11269.44% from -$2.7 million recorded in Q2 2025.
  • In the past 5 years, Voyager Therapeutics' Other Working Capital Changes ranged from a high of $53.3 million in Q1 2022 and a low of -$30.9 million during Q3 2022
  • For the 5-year period, Voyager Therapeutics' Other Working Capital Changes averaged around -$1.8 million, with its median value being -$2.7 million (2025).
  • Examining YoY changes over the last 5 years, Voyager Therapeutics' Other Working Capital Changes showed a top increase of 151880.32% in 2022 and a maximum decrease of 552149.36% in 2022.
  • Over the past 5 years, Voyager Therapeutics' Other Working Capital Changes (Quarter) stood at $1.2 million in 2021, then skyrocketed by 48.89% to $1.8 million in 2022, then tumbled by 479.07% to -$6.8 million in 2023, then surged by 35.96% to -$4.4 million in 2024, then crashed by 152.62% to -$11.1 million in 2025.
  • Its last three reported values are -$11.1 million in Q3 2025, -$2.7 million for Q2 2025, and -$4.5 million during Q1 2025.